Predicting Remission at 6 Months in Early Rheumatoid Arthritis Treated with Conventional Synthetic Dmards

被引：0
|
作者：
Wiese, Michael D. [1 ]
Metcalf, Robert [2 ]
Wechalekar, Mihir D. [3 ]
Spargo, Llew [2 ]
McWilliams, Leah [4 ]
James, Michael [4 ,5 ]
Hill, Catherine [6 ]
Proudman, Susanna [7 ]
机构：
[1] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia
[2] Royal Adelaide Hosp, Rheumatol Unit, Adelaide, SA, Australia
[3] Royal Adelaide Hosp, Adelaide, SA, Australia
[4] Royal Adelaide Hosp, Dept Rheumatol, Adelaide, SA, Australia
[5] Univ Adelaide, Dept Med, Adelaide, SA, Australia
[6] Queen Elizabeth Hosp, Adelaide, SA, Australia
[7] Univ Adelaide, Adelaide, SA, Australia
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
448
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Remission in Early Rheumatoid Arthritis
    Ma, Margaret H. Y.
    Scott, Ian C.
    Kingsley, Gabrielle H.
    Scott, David L.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1444 - 1453
  • [32] Aseptic pyomyositis in rheumatoid arthritis treated with corticosteroid and DMARDs
    Karmacharya, Sudhir
    Shrestha, Adheep Arun
    Nakarmi, Shweta
    Bhochhibhoya, Manisha
    Vaidya, Binit
    OXFORD MEDICAL CASE REPORTS, 2024, 2024 (06): : 245 - 248
  • [33] Predicting Remission at 1 Year in Early Rheumatoid Arthritis: A Subanalysis of PREMIER
    Dougados, Maxime
    Keystone, Edward
    Guerette, Benoit
    Patra, Kaushik
    Lavie, Frederic
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1332 - 1332
  • [34] CLINICAL REMISSION IN SUBJECTS WITH RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB AS MONOTHERAPY OR IN COMBINATION WITH METHOTREXATE OR OTHER SYNTHETIC DMARDS: A REALWORLD CLINICAL TRIAL (TOSPACE)
    Sanmarti, R.
    Martin Mola, E.
    Fonseca, J. E.
    Veale, D. J.
    Escudero, A.
    Gonzalez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 840 - 840
  • [35] The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs
    Soo-Kyung Cho
    Jiyoung Lee
    Minkyung Han
    Sang-Cheol Bae
    Yoon-Kyoung Sung
    Arthritis Research & Therapy, 19
  • [36] COMPARISON OF IMMUNOREGULATORY WITH CONVENTIONAL DMARDS THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Guo, Qiao Ling
    Chen, Li Bao
    Li Zhao-Hua
    Wang, Yan Yan
    Wang, Xin
    Gao, Chong
    Li Xiaofeng
    Wang, Caihong
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1073 - 1074
  • [37] BMI AND PERSISTENCE OF CONVENTIONAL DMARDS & TNF INHIBITORS IN RHEUMATOID ARTHRITIS
    McCulley, C. B.
    Barton, J.
    Cannon, G.
    Sauer, B.
    Teng, C.
    Caplan, L.
    England, B.
    Mikuls, T.
    Baker, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (01) : 77 - 78
  • [38] The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs
    Cho, Soo-Kyung
    Lee, Jiyoung
    Han, Minkyung
    Bae, Sang-Cheol
    Sung, Yoon-Kyoung
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [39] COSTS DESCRIPTION OF RHEUMATOID ARTHRITIS TREATMENT IN CHILE FOR PATIENTS WHO HAVE FAILED TO CONVENTIONAL SYNTHETIC DMARDS
    De la Puente, A. C.
    Zaror, S. C.
    Velasquez, Z. M.
    Medina, Bustos L.
    Gutierrez-Ardila, M., V
    VALUE IN HEALTH, 2015, 18 (03) : A158 - A159
  • [40] Efficacy and safety of baricitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic DMARDs and/or biological DMARDs: Data from a local registry
    Rosas, Jose
    Senabre-Gallego, Jose Miguel
    Santos-Soler, Gregorio
    Bernal, Jose Antonio
    Bas, Ana Pons
    REUMATOLOGIA CLINICA, 2022, 18 (03): : 188 - 189
12345